New anti-coagulant therapies set to revitalise clinical haemotology practice.

Cardiovasc J Afr · 2010 · PMC6107720 · PMID 21135980

Europe PMC

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

‘One RECORD trial on its own met the primary endpoint criteria of superiority, but with the added value of the other two trials, there was a highly significant result in favour of rivaroxaban’, Prof Haas said.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.